Li Kang Biomedical Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	42.93	64.95	111.84	132.01	101.36
Short-Term Investments	132.28	373.6	173.53	117.5	62.5
Trading Asset Securities	15.02	15.86	15.66	13.92	11.89
Cash & Short-Term Investments	190.22	454.4	301.02	263.43	175.75
Cash Growth	-58.14%	50.95%	14.27%	49.89%	-20.33%
Accounts Receivable	9.33	9.51	9.27	10.18	8.08
Receivables	9.33	9.51	9.27	10.18	8.08
Inventory	45.79	45.08	41.59	33.65	31.13
Prepaid Expenses	-	-	-	2.03	1.27
Other Current Assets	7.72	3.71	3.8	-	-
Total Current Assets	253.07	512.71	355.68	309.29	216.23
Property, Plant & Equipment	742.25	420.49	365.63	276.68	362.41
Long-Term Investments	14.73	19.38	20.88	25.38	26.04
Other Intangible Assets	0.78	1.93	1.08	1.68	0.24
Long-Term Deferred Tax Assets	0.52	0.61	0.52	-	0.1
Other Long-Term Assets	81.73	80.5	83.21	75.81	11.06
Total Assets	1,093	1,036	827.01	688.84	616.07
Accounts Payable	43.23	35.92	27.96	43.9	29.46
Accrued Expenses	36.24	37.55	43.32	39.54	30.99
Short-Term Debt	70	-	-	-	-
Current Portion of Long-Term Debt	-	5.36	3.65	-	8.88
Current Portion of Leases	2.81	0.9	-	-	-
Current Income Taxes Payable	9.61	7.46	28.67	28.54	12.09
Other Current Liabilities	6.59	6.86	6.08	6.63	6.92
Total Current Liabilities	168.48	94.05	109.69	118.61	88.34
Long-Term Debt	-	29.64	31.35	-	24.59
Long-Term Leases	53.21	56.02	55.84	-	-
Long-Term Deferred Tax Liabilities	0.13	0.22	0.09	0.09	-
Other Long-Term Liabilities	-	-	-	-	11.14
Total Liabilities	221.82	179.93	196.97	118.7	124.07
Common Stock	318.07	318.07	268.07	233.1	222
Additional Paid-In Capital	213.39	213.39	33.75	33.72	33.72
Retained Earnings	356.77	336.56	339.05	309.64	241.95
Comprehensive Income & Other	-16.98	-12.33	-10.83	-6.33	-5.67
Shareholders' Equity	871.24	855.68	630.03	570.14	492
Total Liabilities & Equity	1,093	1,036	827.01	688.84	616.07
Total Debt	126.02	91.92	90.84	-	33.47
Net Cash (Debt)	64.2	362.48	210.19	263.43	142.28
Net Cash Growth	-82.29%	72.46%	-20.21%	85.15%	-20.78%
Net Cash Per Share	2.01	11.62	7.80	9.77	5.28
Filing Date Shares Outstanding	31.81	31.81	26.81	26.81	26.81
Total Common Shares Outstanding	31.81	31.81	26.81	26.81	26.81
Working Capital	84.59	418.66	245.99	190.68	127.89
Book Value Per Share	27.39	26.90	23.50	21.27	18.35
Tangible Book Value	870.47	853.75	628.95	568.46	491.76
Tangible Book Value Per Share	27.37	26.84	23.46	21.21	18.34
Land	127.19	127.19	127.19	127.19	199.16
Buildings	226.88	226.88	224.6	224.6	227.62
Machinery	47.53	47	41.18	41.55	43.05
Construction In Progress	392.07	58.96	-	-	0.83
Leasehold Improvements	3.14	2.75	1.06	0.63	0.63

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.